Supreme court to hear case challenging FDA's ban of flavored vapes

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

In a case that will test the U.S. Food and Drug Administration's authority to approve or reject new vaping products, the U.S. Supreme Court said Tuesday it will weigh whether the agency was legally allowed to ban flavored e-cigarettes.

Supreme court to hear case challenging FDA's ban of flavored vapes retrieved 2 July 2024 from https://medicalxpress.com/news/2024-07-supreme-court-case-fda-flavored.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Source: Law Daily Report (lawdailyreport.net)

Medicine Research Health Research News Health Research Health Science Medicine Science

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapyThe U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center.
Source: NewsMedical - 🏆 19. / 71 Read more »

The Next Potential Alzheimer’s Drug Clears a Big HurdleIt’s now up to the FDA to decide whether to approve the drug.
Source: TIME - 🏆 93. / 53 Read more »

Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medicationFederal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD—part of a decadeslong effort by psychedelic advocates to win medical acceptance for the drug's purported benefits.
Source: medical_xpress - 🏆 101. / 51 Read more »

FDA Approves Second Alzheimer’s Drug That Can Modestly Slow DiseaseThe Food and Drug Administration approved Eli Lilly’s Kisunla for mild or early cases of dementia caused by Alzheimer’s.
Source: TIME - 🏆 93. / 53 Read more »

Researchers examine cancer drug guidelines and FDA approvalsDrugs for serious or life-threatening diseases can receive expedited U.S. Food and Drug Administration (FDA) review, allowing patients to receive faster access to promising new treatments.
Source: medical_xpress - 🏆 101. / 51 Read more »

Supreme court rejects case that would have curbed access to abortion drugThe U.S. Supreme Court on Thursday threw out a case that aimed to curb access to the controversial abortion drug mifepristone, saying the plaintiffs who brought the case to the court had no legal standing to do so.
Source: medical_xpress - 🏆 101. / 51 Read more »